Third-party educational discussions are available for general informational purposes here
Epidemiological data further demonstrate that over 90% of individuals with BD experience recurrent episodes, which contribute to progressive neurobiological changes, cognitive decline, and increased medical and psychiatric comorbidities (Nierenberg et al., 2023)
doi: 10.1007/s12035-021-02605-5 189 Ebea-UgwuanyiPOVidyasagarSConnorJRFrazerDMKnutsonMDCollinsJF
Common Misconceptions and Marketing Exaggerations Many assume GLP-1 medications lead to dramatic and permanent results for everyone, while real outcomes vary widely
KPV: Anti-Inflammatory Signaling via PepT1 Transport KPV works through a completely different mechanism than BPC-157
Our GLP-1 microdosing programme is tailored to your unique needs, supported by a range of associated services to ensure you feel and look your best throughout your weight loss journey